Galaxy Biomedical Investment Co., Ltd.
Symbol: 000806.SZ
SHZ
0.43
CNYTržní cena dnes
-1.1415
Poměr P/E
0.0445
Poměr PEG
494.96M
MRK Cap
- 0.00%
Výnos DIV
Galaxy Biomedical Investment Co., Ltd. (000806-SZ) finanční výkazy
Rozvaha
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 81.1 | 84.6 | 134.8 | |||||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 3.1 | -64.1 | 24.8 | |||||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 1177.4 | 759.4 | 1146.2 | |||||||||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 199.6 | 280.5 | 233.4 | |||||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 4.7 | 8 | 5.5 | |||||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 1462.8 | 1132.4 | 1519.9 | |||||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 253.5 | 285.9 | 274.1 | |||||||||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 113 | 115.9 | 121.4 | |||||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 113 | 115.9 | 121.4 | |||||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 91.4 | 178.5 | 96.2 | |||||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 19.2 | 21.3 | 29.1 | |||||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 66.6 | 2.2 | 85.8 | |||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 543.7 | 603.8 | 606.7 | |||||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 2006.5 | 1736.2 | 2126.6 | |||||||||||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 285.4 | 261 | 304.1 | |||||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 189.2 | 109.3 | 99.4 | |||||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 45.5 | 28.7 | 20.6 | |||||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 9.3 | 10.6 | 59 | |||||||||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 36.3 | 41.2 | 44.4 | |||||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 569 | 18.1 | 310.2 | |||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 2205.7 | 1830.1 | 924.8 | |||||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 8.7 | 10.6 | 0 | |||||||||||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 3249.4 | 2631.1 | 2063.9 | |||||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 1099.9 | 1099.9 | 1099.9 | |||||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -3534.5 | -3175 | -2195.6 | |||||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 1181.5 | 1189.5 | 1162.6 | |||||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | -1253 | -885.6 | 66.9 | |||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 2006.5 | 1736.2 | 2126.6 | |||||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 10.2 | -9.3 | -4.2 | |||||||||||||||||||||||||||||
balance-sheet.row.total-equity | 0 | -1242.8 | -894.9 | 62.7 | |||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||||||||||||
Total Investments | 0 | 94.5 | 114.4 | 121 | |||||||||||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 198.5 | 119.9 | 158.4 | |||||||||||||||||||||||||||||
balance-sheet.row.net-debt | 0 | 120.5 | 35.3 | 48.4 |
Výkaz peněžních toků
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -336.6 | -968.5 | 62.1 | |||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 46.9 | 47.4 | 28.2 | |||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -229.6 | -94.8 | -74.1 | |||||||||||||||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.inventory | 0 | 80.9 | -47.7 | 26.7 | |||||||||||||||||||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -310.5 | -47.1 | -100.8 | |||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 485.3 | 988.5 | 28.5 | |||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -7 | -22.1 | -18.6 | |||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0.8 | 19.6 | |||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -64.7 | -282.3 | -220.1 | |||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 77.2 | 315.6 | 212.9 | |||||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 1.3 | 2.2 | -18.6 | |||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 6.9 | 14.4 | -24.8 | |||||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -80.9 | -25 | -26 | |||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -4.7 | -4.8 | -8 | |||||||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 104 | 19.7 | 21.6 | |||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 18.4 | -10.1 | -12.4 | |||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0.3 | -0.1 | 0.1 | |||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -8.4 | -23 | 7.5 | |||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 42.2 | 50.6 | 73.6 | |||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 50.6 | 73.6 | 66.1 | |||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -34 | -27.3 | 44.7 | |||||||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -7 | -22.1 | -18.6 | |||||||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -41 | -49.3 | 26.1 |
Řádek výkazu zisku a ztráty
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1528 | 1144.1 | 1106 | |||||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 985.4 | 718.3 | 720.8 | |||||||||||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 542.6 | 425.8 | 385.2 | |||||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 101.3 | 94.5 | 41.9 | |||||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 298.4 | 338.1 | 201.8 | |||||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1283.7 | 1056.4 | 922.6 | |||||||||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 0.2 | 0.3 | 0.2 | |||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 18.9 | 14.5 | 20.2 | |||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -521.4 | -992.9 | -26.5 | |||||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 101.3 | 94.5 | 41.9 | |||||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -521.4 | -992.9 | -26.5 | |||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 18.9 | 14.5 | 20.2 | |||||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 46.9 | 47.4 | 28.2 | |||||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||||||||||||
income-statement-row.row.operating-income | 0 | 218.6 | 59.9 | 109.7 | |||||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | -302.7 | -933 | 83.2 | |||||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 33.9 | 35.5 | 21.1 | |||||||||||||||||||||||||||||
income-statement-row.row.net-income | 0 | -336.6 | -968.5 | 58.3 |
Často kladené otázky
Co je Galaxy Biomedical Investment Co., Ltd. (000806.SZ) celková aktiva?
Galaxy Biomedical Investment Co., Ltd. (000806.SZ) celková aktiva jsou 2006523043.000.
Jaký je roční obrat podniku?
Roční příjmy jsou N/A.
Jaké je ziskové rozpětí podniku?
Zisková marže firmy je 0.350.
Jaký je volný peněžní tok podniku?
Volný peněžní tok je -0.372.
Jaká je čistá zisková marže podniku?
Čistá zisková marže je -0.407.
Jaké jsou celkové tržby podniku?
Celkové příjmy jsou -0.294.
Co je Galaxy Biomedical Investment Co., Ltd. (000806.SZ) čistý zisk (čistý příjem)?
Čistý zisk (čistý příjem) je -336600471.300.
Jaký je celkový dluh podniku?
Celkový dluh je 198468358.000.
Jaké je číslo provozních nákladů?
Provozní výdaje jsou 298367799.000.
Jaké je číslo peněžních prostředků firmy?
Peněžní prostředky podniku jsou 0.000.